Current Results of Combined Coronary Artery Bypass Grafting and Mitral Annuloplasty in Patients with Moderate Ischemic Mitral Regurgitation Farzan Filsoufi, Lishan Aklog, John G. Byrne, Lawrence H. Cohn, David
H. Adams |
|||||
Background and aim of the study: Combined coronary
artery bypass grafting (CABG) and mitral annuloplasty for ischemic mitral
regurgitation (MR) is historically associated with high operative mortality,
and remains controversial in the setting of moderate ischemic MR. Herein,
operative mortality rates in patients undergoing combined CABG and mitral
annuloplasty for moderate ischemic MR were examined. |
during 1996-99 (p = 0.07). Patients from the earlier period
were more likely to have unstable angina, worse NYHA functional class,
and preoperative atrial fibrillation. Patients from the latter period
were more likely to have peripheral vascular disease and chronic obstructive
pulmonary disease. The unadjusted odds ratio (OR) for operative mortality
associated with the earlier era was 4.3 (95% CI 9-20.8; p = 0.07). In
the bivariable logistic regression models, where patient characteristics
that potentially were responsible for the difference in mortality were
added, the OR for operative mortality associated with the 1992-95 era
ranged from 3.4 to 6.7. None of the patient characteristics appreciably
reduced this risk. |
||||
|
|||||